Merit Financial Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.18M | Buy |
60,610
+41,633
| +219% | +$2.87M | 0.05% | 323 |
|
|
2025
Q1 | $1.32M | Sell |
18,977
-263
| -1% | -$18.3K | 0.02% | 555 |
|
|
2024
Q4 | $1.65M | Buy |
19,240
+10,550
| +121% | +$907K | 0.03% | 393 |
|
|
2024
Q3 | $1.03M | Sell |
8,690
-4,706
| -35% | -$560K | 0.02% | 418 |
|
|
2024
Q2 | $1.91M | Sell |
13,396
-506
| -4% | -$72.2K | 0.04% | 275 |
|
|
2024
Q1 | $1.71M | Buy |
13,902
+6,495
| +88% | +$799K | 0.04% | 285 |
|
|
2023
Q4 | $766K | Buy |
7,407
+3,002
| +68% | +$311K | 0.02% | 379 |
|
|
2023
Q3 | $401K | Buy |
4,405
+1,075
| +32% | +$97.8K | 0.01% | 506 |
|
|
2023
Q2 | $270K | Buy |
+3,330
| New | +$270K | 0.01% | 618 |
|